Axogen, Inc.
AXGN
ISIN null / Valor 14092902
Axogen, Inc.
UMushroom community rating:
About company
Axogen, Inc. is a small-cap regenerative medicine company that develops, manufactures and markets surgical products for peripheral nerve repair, centered on its Avance processed human nerve allograft used to bridge nerve gaps as an alternative to autografting; it also offers extracellular-matrix based devices for nerve protection and reconstruction (the Axoguard line) and proprietary tissue-processing and preservation technologies. The company sells these products to hospitals and surgical centers—targeting hand, plastic, orthopedic and neurosurgeons—primarily through a direct commercial organization and distributors internationally, and supports adoption with clinical education and surgeon support. Revenue and growth are driven by procedure adoption, reimbursement dynamics and expansion into new markets.
Summarized from source with an LLMView SourceSector: HealthcareKey figures
Performance
Volatility
2269 M
Market cap (USD)
1,223,566
Daily traded volume (Shares)
/
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
